← Back to Clinical Trials
Recruiting NCT07479186

NCT07479186 Impact of Aortic Diseases on Quality of Life and Work Ability

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07479186
Status Recruiting
Phase —
Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition Aortic Diseases
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2026-03-31
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2026-03-31 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Aortic diseases encompass a wide spectrum of congenital and acquired, acute and chronic conditions, characterized by high clinical and prognostic complexity. The aorta plays a central role in blood flow distribution and hemodynamic modulation owing to its elastic properties, which become progressively impaired with aging and in the presence of genetic or degenerative factors. Beyond clinical outcomes, aortic diseases lead to a marked reduction in health-related quality of life, psychological well-being, and functional capacity, with significant occupational and social consequences, thereby making multidisciplinary management necessary. This longitudinal observational study aims to systematically assess health-related quality of life, fatigue, psychological well-being, and work ability in patients with aortic diseases, with the objective of providing objective bases for occupational risk evaluation and promoting an interdisciplinary management model that integrates clinical, psychological, and work-related aspects, thereby supporting the maintenance or recovery of work functioning.

Eligibility Criteria

Inclusion Criteria: * Male and female patients with a confirmed diagnosis of aortic disease under the care of the Complex Operative Unit of Vascular Surgery of the Fondazione Policlinico Universitario Agostino Gemelli IRCCS. * Patients aged between 18 and 70 years. Exclusion Criteria: * Patients younger than 18 years or older than 70 years. * Incomplete diagnostic workup. * Patients who have undergone surgical procedures or experienced concomitant acute events unrelated to the aorta, with a predominant and recent functional impact, that make it impossible to isolate the effect of aortic disease on return to work.

Contact & Investigator

Central Contact

Ivo Iavicoli, Prof

✉ ivo.iavicoli@unicatt.it

📞 + 39 0630155145

Principal Investigator

Ivo Iavicoli, Prof

PRINCIPAL INVESTIGATOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Frequently Asked Questions

Who can join the NCT07479186 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Aortic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07479186 currently recruiting?

Yes, NCT07479186 is actively recruiting participants. Contact the research team at ivo.iavicoli@unicatt.it for enrollment information.

Where is the NCT07479186 trial being conducted?

This trial is being conducted at Roma, Italy.

Who is sponsoring the NCT07479186 clinical trial?

NCT07479186 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Ivo Iavicoli, Prof at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology